심근 트로포닌 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2034년)
Cardiac Troponin Market (Troponin Type: Troponin I, Troponin T, and Tropinin C, and Setting: Laboratory Setting and Point-of-Care (POC) Testing) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
상품코드:1508535
리서치사:Transparency Market Research
발행일:2024년 05월
페이지 정보:영문 176 Pages
라이선스 & 가격 (부가세 별도)
한글목차
심근 트로포닌 시장 - 조사 범위
TMR의 조사 보고서 "세계의 심근 트로포닌 시장"은 2024년부터 2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사했습니다. 이 보고서는 2024년을 기준연도로, 2034년을 예측 연도로 하여 2018년부터 2034년까지의 세계 심근 트로포닌 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 심근 트로포닌 시장의 복합 연간 성장률(CAGR%)도 제공합니다.
이 보고서는 광범위한 1차 연구, KOL(Key Opinion Leader), 업계 리더 및 오피니언 제조업체와의 인터뷰, 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 문서 등을 참조하여 심근 트로포닌 시장을 추론하는 2차 연구를 통해 작성되었습니다, 심근 트로포닌 시장을 추론했습니다.
시장 현황
2023년 시장 규모
45억 달러
2034년 시장 규모
115억 달러
CAGR
8.9%
이 보고서는 세계 심근 트로포닌 시장의 경쟁 환경을 조사했습니다. 세계 심근 트로포닌 시장에서 사업을 운영하는 주요 기업이 확인되었으며, 각 기업은 다양한 속성으로 프로파일링되었습니다. 기업 개요, 재무 상태, 최근 동향, SWOT 등은 이 보고서에서 다루는 세계 심근 트로포닌 시장 기업의 속성입니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
서론
개요
시장 역학
세계 시장 분석과 예측, 2020-2034년
제5장 주요 인사이트
파이프라인 분석
주요 제품/브랜드 분석
주요 M&A
COVID-19의 산업에 대한 영향
제6장 세계 시장 분석과 예측 : 트로포닌 타입별
서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 트로포닌 타입별, 2020-2034년
Troponin I
Troponin T
Troponin C
시장의 매력 : 트로포닌 타입별
제7장 세계 시장 분석과 예측 : 환경별
서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 환경별, 2020-2034년
실험실 환경
POC(Point of Care)(POC) 검사
시장의 매력 : 환경별
제8장 세계 시장 분석과 예측 : 적응증별
서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 적응증별, 2020-2034년
심근 경색
울혈성 심부전
급성관 증후군
기타(심근증 등)
시장의 매력 : 적응증별
제9장 세계 시장 분석과 예측 : 최종사용자별
서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 최종사용자별, 2020-2034년
병원 및 클리닉
진단 실험실
홈케어 환경
기타(연구기관 등)
시장의 매력 : 최종사용자별
제10장 세계 시장 분석과 예측 : 지역별
주요 조사 결과
시장 매출 예측 : 지역별, 2020-2034년
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장의 매력 : 지역별
제11장 북미 시장 분석과 예측
제12장 유럽 시장 분석과 예측
제13장 아시아태평양 시장 분석과 예측
제14장 라틴아메리카 시장 분석과 예측
제15장 중동 및 아프리카 시장 분석과 예측
제16장 경쟁 구도
시장 기업 - 경쟁 매트릭스(기업 Tier 및 규모별)
시장 점유율 분석 : 기업별(2023년)
기업 개요
F. Hoffmann-La Roche Ltd.
bioMerieux SA
Abbott Laboratories
Siemens Healthineers India
Eurolyser Diagnostica GmbH
QuidelOrtho Corporation
Beckman Coulter, Inc.
Response Biomedical Corporation
LifeSign LLC
LSH
영문 목차
영문목차
Cardiac Troponin Market - Scope of Report
TMR's report on the global cardiac troponin market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global cardiac troponin market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cardiac troponin market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the cardiac troponin market.
Market Snapshot
Market Value in 2023
US$ 4.5 Bn
Market Value in 2034
US$ 11.5 Bn
CAGR
8.9%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global cardiac troponin market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global cardiac troponin market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global cardiac troponin market.
The report delves into the competitive landscape of the global cardiac troponin market. Key players operating in the global cardiac troponin market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global cardiac troponin market profiled in this report.
Key Questions Answered in Global cardiac troponin Market Report:
What is the sales/revenue generated by cardiac troponin across all regions during the forecast period?
What are the opportunities in the global cardiac troponin market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Cardiac Troponin Market - Research Objectives and Research Approach
The comprehensive report on the global cardiac troponin market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global cardiac troponin market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global cardiac troponin market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cardiac Troponin Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cardiac Troponin Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Cardiac Troponin Market Analysis and Forecast, by Troponin Type
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Troponin Type, 2020-2034
6.3.1. Troponin I
6.3.2. Troponin T
6.3.3. Troponin C
6.4. Market Attractiveness, by Troponin Type
7. Global Cardiac Troponin Market Analysis and Forecast, by Setting
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Setting, 2020-2034
7.3.1. Laboratory Setting
7.3.2. Point-of-Care (POC) Testing
7.4. Market Attractiveness, by Setting
8. Global Cardiac Troponin Market Analysis and Forecast, by Indication
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Indication, 2020-2034
8.3.1. Myocardial Infarction
8.3.2. Congestive Heart Failure
8.3.3. Acute Coronary Syndrome
8.3.4. Others (cardiomyopathy, etc.)
8.4. Market Attractiveness, by Indication
9. Global Cardiac Troponin Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2034
9.3.1. Hospitals & Clinics
9.3.2. Diagnostic Laboratories
9.3.3. Homecare Settings
9.3.4. Others (Research Institutes, etc.)
9.4. Market Attractiveness, by End-user
10. Global Cardiac Troponin Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Cardiac Troponin Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Troponin Type, 2020-2034
11.2.1. Troponin I
11.2.2. Troponin T
11.2.3. Troponin C
11.3. Market Attractiveness, by Troponin Type
11.4. Market Value Forecast, by Setting, 2020-2034
11.4.1. Laboratory Setting
11.4.2. Point-of-Care (POC) Testing
11.5. Market Attractiveness, by Setting
11.6. Market Value Forecast, by Indication, 2020-2034
11.6.1. Myocardial Infarction
11.6.2. Congestive Heart Failure
11.6.3. Acute Coronary Syndrome
11.6.4. Others (cardiomyopathy, etc.)
11.7. Market Attractiveness, by Indication
11.8. Market Value Forecast, by End-user, 2020-2034
11.8.1. Hospitals & Clinics
11.8.2. Diagnostic Laboratories
11.8.3. Homecare Settings
11.8.4. Others (Research Institutes, etc.)
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Troponin Type
11.11.2. By Setting
11.11.3. By Indication
11.11.4. By End-user
11.11.5. By Country
12. Europe Cardiac Troponin Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Troponin Type, 2020-2034
12.2.1. Troponin I
12.2.2. Troponin T
12.2.3. Troponin C
12.3. Market Attractiveness, by Troponin Type
12.4. Market Value Forecast, by Setting, 2020-2034
12.4.1. Laboratory Setting
12.4.2. Point-of-Care (POC) Testing
12.5. Market Attractiveness, by Setting
12.6. Market Value Forecast, by Indication, 2020-2034
12.6.1. Myocardial Infarction
12.6.2. Congestive Heart Failure
12.6.3. Acute Coronary Syndrome
12.6.4. Others (cardiomyopathy, etc.)
12.7. Market Attractiveness, by Indication
12.8. Market Value Forecast, by End-user, 2020-2034
12.8.1. Hospitals & Clinics
12.8.2. Diagnostic Laboratories
12.8.3. Homecare Settings
12.8.4. Others (Research Institutes, etc.)
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Troponin Type
12.11.2. By Setting
12.11.3. By Indication
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Cardiac Troponin Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Troponin Type, 2020-2034
13.2.1. Troponin I
13.2.2. Troponin T
13.2.3. Troponin C
13.3. Market Attractiveness, by Troponin Type
13.4. Market Value Forecast, by Setting, 2020-2034
13.4.1. Laboratory Setting
13.4.2. Point-of-Care (POC) Testing
13.5. Market Attractiveness, by Setting
13.6. Market Value Forecast, by Indication, 2020-2034
13.6.1. Myocardial Infarction
13.6.2. Congestive Heart Failure
13.6.3. Acute Coronary Syndrome
13.6.4. Others (cardiomyopathy, etc.)
13.7. Market Attractiveness, by Indication
13.8. Market Value Forecast, by End-user, 2020-2034
13.8.1. Hospitals & Clinics
13.8.2. Diagnostic Laboratories
13.8.3. Homecare Settings
13.8.4. Others (Research Institutes, etc.)
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Troponin Type
13.11.2. By Setting
13.11.3. By Indication
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Cardiac Troponin Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Troponin Type, 2020-2034
14.2.1. Troponin I
14.2.2. Troponin T
14.2.3. Troponin C
14.3. Market Attractiveness, by Troponin Type
14.4. Market Value Forecast, by Setting, 2020-2034
14.4.1. Laboratory Setting
14.4.2. Point-of-Care (POC) Testing
14.5. Market Attractiveness, by Setting
14.6. Market Value Forecast, by Indication, 2020-2034
14.6.1. Myocardial Infarction
14.6.2. Congestive Heart Failure
14.6.3. Acute Coronary Syndrome
14.6.4. Others (cardiomyopathy, etc.)
14.7. Market Attractiveness, by Indication
14.8. Market Value Forecast, by End-user, 2020-2034
14.8.1. Hospitals & Clinics
14.8.2. Diagnostic Laboratories
14.8.3. Homecare Settings
14.8.4. Others (Research Institutes, etc.)
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Troponin Type
14.11.2. By Setting
14.11.3. By Indication
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Cardiac Troponin Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Troponin Type, 2020-2034
15.2.1. Troponin I
15.2.2. Troponin T
15.2.3. Troponin C
15.3. Market Attractiveness, by Troponin Type
15.4. Market Value Forecast, by Setting, 2020-2034
15.4.1. Laboratory Setting
15.4.2. Point-of-Care (POC) Testing
15.5. Market Attractiveness, by Setting
15.6. Market Value Forecast, by Indication, 2020-2034
15.6.1. Myocardial Infarction
15.6.2. Congestive Heart Failure
15.6.3. Acute Coronary Syndrome
15.6.4. Others (cardiomyopathy, etc.)
15.7. Market Attractiveness, by Indication
15.8. Market Value Forecast, by End-user, 2020-2034
15.8.1. Hospitals & Clinics
15.8.2. Diagnostic Laboratories
15.8.3. Homecare Settings
15.8.4. Others (Research Institutes, etc.)
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Troponin Type
15.11.2. By Setting
15.11.3. By Indication
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
16.3.1. F. Hoffmann-La Roche Ltd.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. bioMerieux SA
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Abbott Laboratories
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Siemens Healthineers India
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Eurolyser Diagnostica GmbH
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. QuidelOrtho Corporation
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Beckman Coulter, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Response Biomedical Corporation
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. LifeSign LLC
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
